Widespread morbilliform rash due to sorafenib or vemurafenib treatment for advanced cancer; experience of a tertiary dermato-oncology clinic
| Image |  |
|---|---|
| Description | scientific article published on 29 January 2016 |
| Author/s |
author: Emmilia Hodak Michal Lotem |
| Publication date | January 29, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |